ClearPoint Neuro (CLPT) Debt Ratio (2011 - 2026)

ClearPoint Neuro (CLPT) posted Debt Ratio of 0.53 for Q1 2026, up 5.85% sequentially from 0.5 in Q4 2025.

ClearPoint Neuro (CLPT) Debt Ratio (2011 - 2026) Analysis & Trends

ClearPoint Neuro has reported Debt Ratio for 16 years, with the latest figure at 0.53 in Q1 2026.

Quarterly Debt Ratio changed N/A year-over-year to 0.53 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.53 (changed N/A YoY) and the FY2025 annual result came in at 0.5, changed N/A from the prior year.
Debt Ratio climbed to 0.53 in Q1 2026 per CLPT's latest filing, from 0.5 in the prior quarter.
Over five years, Debt Ratio peaked at 0.53 in Q1 2026 and troughed at 0.16 in Q1 2022.
A 5-year average of 0.28 and a median of 0.21 in 2023 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2022 and 2023: Debt Ratio plunged 51.69% in 2022, then soared 32.46% in 2023.
Over 5 years, Debt Ratio stood at 0.18 in 2022, then soared by 30.81% to 0.23 in 2023, then dropped by 20.34% to 0.19 in 2024, then surged by 170.27% to 0.5 in 2025, then grew by 5.85% to 0.53 in 2026.
According to Business Quant data, Debt Ratio over the past three periods registered 0.53, 0.5, and 0.48 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	199.24 Bn	193.64 Bn	7.27 Bn	0.30
2	Stryker	128.63 Bn	125.15 Bn	4.50 Bn	0.31
3	Medtronic	119.19 Bn	109.97 Bn	6.41 Bn	0.30
4	Boston Scientific	73.51 Bn	72.97 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	52.11 Bn	47.85 Bn	1.35 Bn	0.04
6	Dexcom	34.64 Bn	32.70 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.01 Bn	31.90 Bn	2.18 Bn	0.27
8	Koninklijke Philips	26.40 Bn	23.08 Bn	4.55 Bn	0.28
9	Steris	23.14 Bn	22.65 Bn	684.20 Mn	0.18
10	ClearPoint Neuro	467.73 Mn	438.33 Mn	6.71 Mn	0.58

Download Data